MedTrace Logo

The Sapienza University Mortality and Morbidity Events Rate (SUMMER) Study in Diabetes

NCT02311244 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5139

Last updated 2023-05-12

No results posted yet for this study

Summary

This observational study is aimed at identifying new molecular promoters of mortality (and morbidity) in patients with type 2 diabetes mellitus (T2DM).

Conditions

Sponsors & Collaborators

  • Campus Bio-Medico University

    collaborator OTHER

  • Ospedale Sandro Pertini, Roma

    collaborator OTHER

  • Azienda Ospedaliera San Camillo Forlanini

    collaborator OTHER

  • University of Cagliari

    collaborator OTHER

  • Casa Sollievo della Sofferenza IRCCS

    collaborator OTHER

  • University of Roma La Sapienza

    lead OTHER

Principal Investigators

  • Vincenzo Trischitta, MD · University of Roma La Sapienza

  • Giuseppe Pugliese, MD, PhD · University of Roma La Sapienza

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2020-12-31
Completion
2022-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02311244 on ClinicalTrials.gov